OBERON GROUP
Baskerville Cap PLC – Final Results
5 October 2018
BASKERVILLE CAPITAL PLC (“Baskerville” or “the Company”) Financial results for the period ended 30 June 2018. Baskerville (ticker: BASK) announces its audited financial results for the period ended 30 June 2018.
Period highlights
- On 22 September 2017, the Company was admitted to the standard segment of the Official List and to trading on the London Stock Exchange’s Main Market
- The Company was formed to undertake an acquisition in the technology sector
- Raised £1.8 million cash (gross) through the listing of 36,000,000 new ordinary shares
- Loss for the period of £168,934 with over £1.6m cash at period end and no debt financing
Rodger Sargent, Chairman of Baskerville said: “A number of technology companies, within different sectors and at different stages of their corporate development, have been considered since Baskerville floated last year. We have reached various stages of negotiation, but none have yet met the standards we have set to generate significant shareholder value. We continue to put all our efforts into identifying and acquiring such a company and will update further as soon as we are able.”
For further information, please contact:
Baskerville Capital plc www.baskcap.com
Rodger Sargent via Walbrook PR
Walbrook PR Ltd
020 7933 8780 or baskerville@walbrookpr.com
CHAIRMAN’S STATEMENT FOR THE PERIOD ENDED 30 JUNE 2018
INTRODUCTION
I am pleased to present the financial results for the period ended 30 June 2018. Baskerville Capital plc incorporated on the 6 April 2017 and floated on the London Stock Exchange on 22 September 2017. The Company was created to acquire businesses with a technology focus.
BUSINESS REVIEW
During this period, Baskerville Capital Plc recorded a loss of £168,934 and the loss per share was 0.50p. This reflects the costs of the formation of the Company and its admission to the London Stock Exchange. £53,252 of these expenses are a non-cash accounting charge relating to issued options. The Company held cash reserves at the period end of over £1.6m with no debt financing.
FUTURE DEVELOPMENTS
We continue to consider various technology based companies. Nothing has yet met our strict criteria to generate significant shareholder value but our analysis and research into opportunities continues. We are currently looking at a number of deals and will update the market accordingly.
Rodger Sargent
Chairman
4 October 2018
STRATEGIC REPORT FOR THE PERIOD ENDED 30 JUNE 2018
The Directors present the Strategic Report for the period ended 30 June 2018.
The Company incorporated on 6 April 2017 as Baskerville Capital plc.
RESULTS
The Company made a loss for the year of £168,934.
REVIEW OF THE BUSINESS AND FUTURE DEVELOPMENTS
Information on the Company’s activities is contained in the Chairman’s Statement on page 2.
KEY PERFORMANCE INDICATORS
The Board seeks to maximise share value by investing in businesses with high growth potential. When an investment has been identified, the Board will assess it against a number of KPI’s to assess its suitability.
PRINCIPAL RISKS AND UNCERTAINTIES AND RISK MANAGEMENT
Capital risk management
The Company manages its capital to ensure that it will be able to continue as a going concern while maximising returns to the shareholders. It is the current strategy of the Group to finance its activities from existing equity and reserves and by the issue of new equity whenever required.
Financial risk management
The directors consider the Company to be exposed to the following financial risks:
a. Price risk: the price paid for securities is subject to market movement that will have an impact on the operations of the Company.
Given the relatively small sized and operation of the Company in the period, the directors have not delegated the responsibility of risk monitoring to a sub-committee of the board, but will closely monitor the risks on a regular basis. The directors consider their exposure in the financial period to have been low.
Rodger Sargent
CEO
4 October 2018
STATEMENT OF COMPREHENSIVE INCOME FOR THE PERIOD ENDED 30 JUNE 2018
There was no other comprehensive income in 2018.
The notes below form part of these financial statements.
STATEMENT OF FINANCIAL POSITION AS AT 30 JUNE 2018
These financial statements were approved by the Board of Directors on 4 October 2018 and were signed on its behalf by:
Rodger Sargent (CEO)
The notes below form part of these financial statements.
STATEMENT OF CHANGES IN EQUITY FOR THE PERIOD ENDED 30 JUNE 2018
Share premium is stated net of issue costs of £233,506.
The notes below form part of these financial statements.
STATEMENT OF CASH FLOWS FOR THE PERIOD ENDED 30 JUNE 2018
The notes below form part of these financial statements.
NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 JUNE 2018
1. GENERAL INFORMATION
Baskerville Capital plc is a public limited company registered and incorporated in the England and Wales. The Company’s principal activities are described in the Directors’ Report. The Company’s registered office and principal place of business is c/o Locke Lord, 2nd floor, 201 Bishopsgate, London EC2M 3AB.
2. ACCOUNTING POLICIES
The financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union. The financial statements have been prepared using the measurement bases specified by IFRS for each type of asset, liability, income and expense. The measurement bases are more fully described in the accounting policies below.
The financial statements are presented in pounds sterling (£) which is the functional currency of the company.
An overview of standards, amendments and interpretations to IFRSs issued but not yet effective, and which have not been adopted early by the Company are presented below under ‘Statement of Compliance’.
Statement of compliance
The financial statements comply with IFRS as adopted by the European Union. At the date of authorisation of these financial statements the following Standards and Interpretations affecting the Company, which have not been applied in these financial statements, were in issue, but not yet effective. The company does not plan to adopt these standards early.
· Amendments to IFRS 2 Share Based Payment (effective for accounting periods beginning on or after 1 January 2018)
· IFRS 15 Clarification of Revenue from Contracts with Customers (effective for accounting periods beginning on or after 1 January 2018)
· IFRS 16 Leases (effective for accounting periods beginning on or after 1 January 2019)
Going Concern
The directors have assessed the Company’s position as at 30 June 2018 and consider it appropriate to prepare the financial statements on a going concern basis. There are cash reserves of £1.6m which the directors consider sufficient to ensure that the Company will be able to continue to meet its commitments as they fall due for at least twelve months from the date of approval of the financial statements.
Segment reporting
A business segment is a group of assets and operations engaged in providing products or services that are subject to risks and returns that are different from those of other business segments. A geographical segment is engaged in providing products or services within a particular economic environment that are subject to risks and returns that are different from those of segments operating in other economic environments.
The directors are of the opinion that the Company is not currently engaged in any more than a single sector as it has not yet traded and has incurred only set up fees and the costs of running a business for the period. The Company is based in the United Kingdom and accordingly, no segmental analysis is considered necessary.
Expenses
All expenses are accounted for on an accruals basis and are presented through the Statement of Comprehensive Income.
Share based payments
All share based payments are accounted for in accordance with IFRS 2 – Share-based payments. The Company issues equity-settled share based payments in the form of options and warrants to certain directors and employees. Equity settled share based payments are measured at fair value at the date of grant. The fair value determined at the grant date of equity-settled share based payments is expensed on a straight line basis over the vesting period, based on the Company’s estimate of shares that will eventually vest.
Share based payments (continued)
Fair value is estimated using the Black-Scholes valuation model. The expected life used in the model has been adjusted, on the basis of management’s best estimate for the effects of non-transferability, exercise restrictions and behavioural considerations. At each balance sheet date, the Company revises its estimate of the number of equity instruments expected to vest as a result of the effect of non-market based vesting conditions. The impact of the revision of the original estimates, if any, is recognised in profit or loss such that the cumulative expense reflects the revised estimate, with a corresponding adjustment to retained earnings.
Taxation
Current taxation is the taxation currently payable on taxable profit for the year.
Trade and other receivables
Trade and other receivables are recognised and carried at original invoice value less an allowance for any uncollectible amounts. An estimate for doubtful debts is made when collection of the full amount is no longer probable. Bad debts are written off when identified.
Cash and Cash equivalents
Cash and cash equivalents comprise cash on hand and demand deposits, together with other short-term, highly liquid investments that are readily convertible into known amounts of cash and which are subject to an insignificant risk of changes in value.
Trade payables
Trade payables are initially measured at fair value and are subsequently measured at amortised cost, using the effective interest rate method.
Financial instruments
The Company’s financial assets comprise cash and cash equivalents.
The Company’s financial liabilities comprise trade payables. Financial liabilities are obligations to pay cash or other financial assets and are recognised when the Company becomes a party to the contractual provisions of the instruments.
Equity
Equity comprises the following:
· “Share capital” represents the nominal value of equity shares.
· “Share premium” represents the excess over nominal value of the fair value of consideration received for equity shares, net of expenses of the share issue.
· “Share option reserve” represents the value of warrants and options issued.
· “Retained losses” represents cumulative net gains and losses recognised in the Statement of Comprehensive Income.
Critical Accounting Estimates and Judgements
The preparation of financial statement in conformity with IFRS requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting year. These estimates and assumptions are based upon management’s knowledge and experience of the amounts, events or actions. Actual results may differ from such estimates.
3. SEGMENTAL INFORMATION
The Company is organised around one business class and the results are reported to the Chief Operating Decision Maker according to this class. There is one continuing class of business, being the investment in the medical technology industry.
Given that there is only one continuing class of business, operating within the UK no further segmental information has been provided.
No deferred tax asset has been recognised as the Directors cannot be certain that future profits will be sufficient for this asset to be realised.
Factors affecting future tax charges
There are no factors affecting the tax charge.
The Directors consider that the carrying amount of cash and cash equivalent represents their fair value.
The fair value of trade and other payables is considered by the Directors not to be materially different to carrying amounts.
Fully paid ordinary shares, which have a par value of 2.5p, carry one vote per share and rank equally in respect of dividends.
EQUITY SETTLED SHARE OPTION SCHEME
The Company operates share-based payment arrangements to remunerate directors and key employees in the form of options and warrants. The Company also issued warrants to shareholders during the period. Equity-settled share-based payments are measured at fair value (excluding the effect of non-market based vesting conditions) at the date of grant. The fair value determined at the grant date of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of shares that will eventually vest and adjusted for the effect of non-market based vesting conditions.
The following table sets out the details of these options granted:
The fair value of the warrants issued to directors was determined using the Black-Scholes option pricing model and the inputs to the model were as follows
Warrants issued to shareholders were issued as one warrant for every four ordinary shares purchased. As they were part of the fundraise they have not been valued under IFRS 2.
The total share-based payment expense recognised in the statement of comprehensive income for the period ended 30 June 2018 in respect of these options granted was £53,252.
13. CAPITAL MANAGEMENT
The Company manages its capital to ensure that it will be able to continue as a going concern while maximising returns to shareholders. It is the current strategy of the Company to finance its activities from existing equity and reserves and by the issue of new equity as required.
The Board’s policy is to maintain a strong capital base so as to maintain investors, creditors and market confidence and to sustain future development of the business. The Board manages the Company’s affairs to achieve shareholders returns through capital growth and income.
The Company is not subject to externally imposed capital requirements.
14. LOSS PER SHARE
The calculation of loss per ordinary share is based on the loss attributable to ordinary shareholders divided by the weighted average number of shares in issue during the year.
There is no difference between the basic and diluted loss per share.
15. NET ASSET VALUATION
The net asset valuation per share is calculated by dividing the net assets attributable to the equity holders of the Company at the end of the reporting period by the number of shares in issue.
16. FINANCIAL INSTRUMENTS
The Company’s activities expose it to a variety of financial risks: market risk, credit risk, liquidity risk, cash flow interest rate risk and equity price risk.
Risk management is carried out by the Board of Directors.
(a) Capital management
The Company’s objectives when managing capital are:
· to safeguard the Company’s ability to continue as a going concern, so that it continues to provide returns and benefits for shareholders;
· to support the Company’s growth; and
· to provide capital for the purpose of strengthening the Company’s risk management capability.
The Company actively and regularly reviews and manages its capital structure to ensure an optimal capital structure and equity holder returns, taking into consideration the future capital requirements of the Company and capital efficiency, prevailing and projected profitability, projected operating cash flows, projected capital expenditures and projected strategic investment opportunities. Management regards total equity as capital and reserves, for capital management purposes.
(b) Credit risk
The main credit risk relates to liquid funds held at banks. The credit risk in respect of these bank balances is limited because the counterparties are banks with high credit ratings assigned by international credit rating agencies.
(c) Liquidity risk
The Company seeks to manage financial risk, to ensure sufficient liquidity is available to meet foreseeable needs.
An analysis of trade and other payables is given in note 10. These payables are payable within a year.
CATEGORIES OF FINANCIAL INSTRUMENTS
The IAS 39 categories of financial asset included in the statement of financial position and the headings in which they are included are as follows:
17. RELATED PARTY TRANSACTIONS
There were no related party transactions with the directors during the year other than those disclosed in note 12. The directors consider themselves to be the key management personnel.
18. ULTIMATE CONTROLLING PARTY
The directors do not consider there to be one ultimate controlling party.